首页> 外文期刊>The Internet Journal of Dermatology >Skin As A Reflection Of Hepatitis C Virus Infection And Adverse Effects Of Its Treatment
【24h】

Skin As A Reflection Of Hepatitis C Virus Infection And Adverse Effects Of Its Treatment

机译:皮肤反映丙型肝炎病毒感染及其治疗的不良反应

获取原文
       

摘要

Sir,Hepatitis C viral infection (HCV) is a major global health concern with 170 million people affected worldwide there are estimated 12 -13 million carriers in India presently1. Currently the combination of peg interferon and ribavarin is considered the standard treatment of HCV infection2. Although combination of these two drugs is most effective but it is also associated with increased risk of side effects due to immunomodulatory effect of both the drugs3. Dermatological side effects in the form of skin rashes, dryness, pruritus, pyoderma gangrenosum, alopecia, toxic epidermal necrolysis, new or exacerbation of psoriasis, induration and ulceration at the injection site can occur4. On the other hand various skin disorders such as lichen planus, necrotising vasculitis or porphyria cutanea tarda are more commonly associated with hepatitis C infection5.We as dermatologist are referred cases with cutaneous manifestations from various specialties and should be aware whether these changes are due to disease itself or its treatment. We observed 30 HCV positive and HIV negative cases with dermatological manifestations (Table- 1) on combination treatment with Ribavarin and peginterferon who came to our OPD over a period of two years for skin opinion. Out of those 30 cases, 28 patients were males and only 2 were females. They were in the age range 35 to 55 years. All of them were on a regimen of peginterferon 180mcg weekly and Ribavarin 1000mg daily for 24 weeks. All the cases were diagnosed clinically and were supported by skin biopsy where ever required. Majority of these cases belonged to genotype 3 and 4.In all the cases we took detailed history with regard to the clinical pattern of dermatological manifestation, temporal relation between drug use and onset of skin lesions, history of intake of any other drug, whether similar skin lesions were also present prior to initiation of treatment, route and frequency of drug administration as devised by Sacredots et al6.
机译:主席先生,丙型肝炎病毒感染(HCV)是全球主要的健康问题,全世界有1亿7千万人受到感染,目前印度估计有12 -13百万携带者1。目前,聚乙二醇干扰素和利巴韦林的组合被认为是HCV感染的标准治疗方法2。虽然这两种药物的组合最有效,但由于两种药物的免疫调节作用,它还增加了副作用的风险3。皮肤出现皮疹,干燥,瘙痒,坏疽性脓皮病,脱发,皮肤毒性中毒坏死,牛皮癣的新发或加剧,注射部位硬结和溃疡等形式的皮肤病副作用4。另一方面,各种皮肤疾病,例如扁平苔藓,坏死性脉管炎或皮肤卟啉病,更常见于丙型肝炎感染5.作为皮肤科医生,我们转诊了各种专业的皮肤表现病例,应注意这些变化是否是由于疾病引起的本身或其治疗。我们观察了30例经利巴韦林和聚乙二醇干扰素联合治疗的皮肤病学表现为HCV阳性和HIV阴性的皮肤病学表现(表1),他们在两年内进入我们的OPD进行皮肤检查。在这30例病例中,男性28例,女性2例。他们的年龄在35至55岁之间。所有这些患者每周接受一次聚乙二醇干扰素180mcg的治疗,每天服用瑞巴伐林1000mg的治疗24周。所有病例均经过临床诊断,并在需要时进行皮肤活检。这些病例大多数属于基因型3和4。在所有病例中,我们均详细了解了皮肤病学表现的临床模式,用药与皮肤病变发作之间的时间关系,是否服用了其他药物,是否相似。如Sacredots等人[6]所设计的,在开始治疗,药物给药的途径和频率之前还存在皮肤损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号